During the past decade, Premier Cardiology, Inc conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Premier Cardiology, Inc" are "Heart Failure" (4 trials), "Bradycardia" (3 trials), "Cardiac Rhythm Disorder" (2 trials) and "Cardiac Pacemaker, Artificial" (1 trials). Many other conditions were trialed in "Premier Cardiology, Inc" in a lesser frequency.

Most popular intervention types in "Premier Cardiology, Inc" are "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Aveir DR Leadless Pacemaker System" (1 trials), "Aveir VR Leadless Pacemaker System" (1 trials), "BiV/MPP" (1 trials), "CRT-D System" (1 trials) and "Leadless Pacemaker" (1 trials). Other intervention names were less common.

The vast majority of trials in "Premier Cardiology, Inc" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Premier Cardiology, Inc". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Premier Cardiology, Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Premier Cardiology, Inc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".